Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Shandong Chenghui Shuangda Pharmaceutical

02 1Shanghai Minbiotech

03 1Hiray Pharma Solutions

04 1Sichuan Taienkang Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
2212021-56-0
Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in API and advanced intermediate R&D...
Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in API and advanced intermediate R&D and manufacturing, delivering comprehensive CDMO/CRO/OEM services and Finished Formulation Technology Transfer. With 24 years' expertise, our 6 GMP workshops ensure 100-ton monthly cGMP-compliant capacity. We hold 21 NMPA-registered APIs, 4 US-DMF filings, 8 CEP applications, and passed US FDA, Korea MFDS, and global client audits. Note: Patent-protected products are for R&D use only per Patent Act, not for commercial sale.
Shandong Chenghui Shuangda Pharmaceutical
2212021-56-0
Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediat...
Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Shanghai Minbiotech CB
2212021-56-0
Hiray Pharma Solutions is a global end-to-end CDMO specializing in APIs and intermediates. The compa...
Hiray Pharma Solutions is a global end-to-end CDMO specializing in APIs and intermediates. The company offers integrated services across Process R&D, Analytical R&D, manufacturing, and Quality Control, enabling efficient scale-up and commercialization. With strong expertise in chemical synthesis and process optimization, Hiray ensures regulatory compliance, EHS standards, and IP protection while delivering high-quality products on time to pharmaceutical partners worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

03

Hiray Pharma Solutions

Orforglipron Intermediate

CAS Number : 2212021-56-0

End Use API : Orforglipron Calcium Hydrate

About the Company : Hiray Pharma Solutions is a global end-to-end CDMO specializing in APIs and intermediates. The company offers integrated...

Company Banner
2212021-56-0
Sichuan Taienkang Pharmaceutical Co., Ltd., established in 2020, is a subsidiary of Guangdong Taienk...
Sichuan Taienkang Pharmaceutical Co., Ltd., established in 2020, is a subsidiary of Guangdong Taienkang Pharmaceutical Co., Ltd. The company specializes in the R&D, production, and sales of generic APIs and intermediates, focusing on high-value APIs such as Dapoxetine Hydrochloride, Tadalafil, and others to meet diverse market needs. Located in the Yuechi Economic Development Zone, Sichuan Province, the manufacturing site spans 100 acres within a provincial-level chemical industry park. Phase one includes 4 independent production lines and a Class D GMP workshop, equipped with 500L to 5000L multifunctional reactors.
blank